Home/Sana Biotechnology/Dhavalkumar Patel
DP

Dhavalkumar Patel

Chief Scientific Officer

Sana Biotechnology

Sana Biotechnology Pipeline

DrugIndicationPhase
UP421Type 1 diabetesPre-Clinical
SC451Type 1 diabetesPre-Clinical
SG293B-cell Malignancies (Oncology) & B-cell Related Autoimmune DiseasesPre-Clinical